A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 36, Issue 3, 2007, Pages 142-146

  Thongprasom, Kobkan ^a   Chaimusig, Mantharop ^b   Korkij, Wiwat ^a   Sererat, Thanasit ^a   Luangjarmekorn, Lakana ^a   Rojwattanasirivej, Somsri ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Saraburi Hospital   (Thailand)

Author keywords

Cyclosporin; Oral lichen planus; Triamcinolone acetonide

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BREAST TENDERNESS; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LICHEN PLANUS; MALE; PAIN; PAIN ASSESSMENT; PETECHIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SWELLING; THAILAND; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PAIN MEASUREMENT; STATISTICS, NONPARAMETRIC; TRIAMCINOLONE ACETONIDE;

EID: 33846962437     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00510.x     Document Type: Article

References (25)

1. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus; report of an international consensus meeting: Part 1. Viral infections and aetiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 40-51.
2. Carrozzo M, Gandolfo S. The management of oral lichen planus. Oral Dis 1999; 5: 196-205.
3. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-14.
4. Voute AB, Schulten EA, Langendijk PN, Nieboer C, van der Waal I. Cyclosporin A in an adhesive base for treatment of recalcitrant oral lichen planus. An open trial. Oral Surg Oral Med Oral Pathol 1994; 78: 437-41.
5. Bunjes D, Hardt C, Rollinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 1981; 11: 657-61.
6. Nickoloff BJ. Role of interferon-γ in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatol 1988; 124: 1835-43.
7. Eisen D, Ellis CN, Duell EA, Griffiths CE, Voorhees JJ. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med 1990; 323: 290-4.
8. Harpenau LA, Plemons JM, Rees TD. Effectiveness of a low dose of cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 161-7.
9. Lopez Lopez J, Rosello Llabres X. Cyclosporine A, an alternative to the oral lichen planus erosive treatment. Bull Group Int Rech Sci Stomatol Odontol 1995; 38: 33-8.
10. Epstein JB, Truelove EL. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 532-6.
11. Becherel PA, Chosidow O, Boisnic S, Moyal-Barraco M, Pelisse M, Reigneau O, et al. Topical cyclosporine in the treatment of oral and vulvar erosive lichen planus: a blood level monitoring study. Arch Dermatol 1995; 131: 495-6.
12. Jungell P, Malmstrom M. Cyclosporin A mouthwash in the treatment of oral lichen planus. Int J Oral Maxillofac Surg 1996; 25: 60-2.
13. Sieg P, Von Domarus H, Von Zitzewitz V, Iven H, Farber L. Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br J Dermatol 1995; 132: 790-4.
14. Conrotto D, Carbone M, Carrozzo M, et al. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 2006; 154: 139-45.
15. Yoke PC, Tin GB, Kim MJ, et al. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 47-55.
16. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. WHO collaborating centre for oral precancerous lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-39.
17. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992; 21: 456-8.
18. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976; 2: 175-84.
19. Itin P, Surber C, Buchner S. Lack of effect after local treatment with a new ciclosporin formulation in recalcitrant erosive oral lichen planus. Dermatology 1992; 185: 262-5.
20. Pacor ML, Biasi D, Urbani G, Lombardo G, Lunardi C. The efficacy of cyclosporine for topical use in oral lichen planus. Minerva Stomatol 1994; 43: 129-32.
21. Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C. Topicalcorticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999; 5: 44-9.
22. Hegarty AM, Hodgson TA, Lewsey JD, Porter SR. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol 2002; 47: 271-9.
23. Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 2003; 32: 323-9.
24. Campisi G, Giandalia G, De Caro V, Di Liberto C, Arico P, Giannola LI. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A phase IV, randomized, observer-blinded, parallel group clinical trial. Br J Dermatol 2004; 150: 984-90.
25. Thongprasom K, Dhanuthai K, Sarideechaigul W, Chaiyarit P, Chaimusig M. Expression of TNF-α in oral lichen planus treated with fluocinolone acetonide 0.1%. J Oral Pathol Med 2006; 35: 161-6.